Full kringles of plasminogen (aa 1-566) mediate complete regression of human MDA-MB-231 breast tumor xenograted in nude mice

Gene Therapy

Volumn 12, Issue 10, 2005, Pages 831-842

  Galaup, A ^a   Magnon, C ^a   Rouffiac, V ^b   Opolon, P ^a   Opolon, D ^a   Lassau, N ^b   Tursz, T ^b   Perricaudet, M ^a   Griscelli, F ^a  

^a CNRS   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Adenovirus; Antiangiogenesis; Cancer; K1 5 (aa 1 566)

Indexed keywords

ADENOVIRUS VECTOR; CASPASE; CYSTEINE; DISULFIDE; PLASMINOGEN;

AMINO TERMINAL SEQUENCE; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST TUMOR; CANCER INHIBITION; CANCER INVASION; CELL ASSAY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION FUNCTION; DISULFIDE BOND; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENCY; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; KRINGLE DOMAIN; LUNG METASTASIS; MELANOMA CELL; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; TUMOR CELL LINE; TUMOR REGRESSION; TUMOR XENOGRAFT; VASCULAR ENDOTHELIUM; VIRAL GENE DELIVERY SYSTEM; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; BREAST NEOPLASMS; FEMALE; GENE THERAPY; GENETIC VECTORS; HUMANS; KRINGLES; LUNG NEOPLASMS; MELANOMA; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PLASMINOGEN; RANDOM ALLOCATION; TRANSPLANTATION, HETEROLOGOUS;

ADENOVIRIDAE; MUS MUSCULUS;

EID: 19944424478     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302474     Document Type: Article

References (32)

1. Hanahan D, Folkman J. Patterns and emerging, mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353-364.
2. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27-31.
3. O'Reilly MS et al. Angiostatin: a novel angiogenesis inhibitor that mediated the suppression of metastases by Lewis lung carcinoma. Cell 1994; 79: 315-328.
4. O'Reilly MO et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277-285.
5. Kamphaus GD et al. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem 2000; 275: 1209-1215.
6. Clapp C et al. The 16 kDa N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 1993; 133: 1292-1299.
7. Gupta SK, Hassel T, Singh JP. A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4. Proc Natl Acad Sci USA 1995; 92: 7799-7803.
8. Gately S et al. Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin. Cancer Res 1996; 56: 4887-4890.
9. O'Mahony CA et al. Angiostatin generation by human pancreatic cancer. J Surg Res 1998; 77: 55-58.
10. Westphal JR et al. Angiostatin generation by human tumor cell lines: involvement of plasminogen activator. Int J Cancer 2000; 86: 760-767.
11. Cao Y et al. Kringle domains of human angiostatin. J Biol Chem 1996; 271: 29461-29467.
12. Ji RW et al. Characterization of kringle domains of angiostatin as antagonist of endothelial cell migration, an important process in angiogenesis. FASEB J 1998; 12: 1731-1738.
13. Tanaka T, Cao Y, Folkman J, Fine HA. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA. Cancer Res 1998; 58: 3362-3369.
14. McDonald NJ et al. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3. Biochem Biophys Res Commun 1999; 264: 469-477.
15. Cao Y et al. Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J Biol Chem 1997; 272: 22924-22928.
16. Ji RW et al. Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis. Biochem Biophys Res Commun 1998; 247: 414-419.
17. Cao R et al. Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis. Proc Natl Acad Sci USA 1999; 96: 5728-5733.
18. Li F et al. Human glioma cell BT325 expresses a proteinase that converts human plasminogen to kringle 1-5-containing fragments. Biochem Biophys Res Commun 2000; 278: 821-825.
19. Handford AH et al. Angiostatin 4.5-mediated apoptosis of vascular endothelial cells. Cancer Res 2003; 63: 4275-4280.
20. Bouquet C, Frau E et al. Systemic administration of a recombinant adenovirus encoding a HSA-angistatin kringle 1-3 conjugate inhibits MDA-MB-231 tumor growth and metastasis in a transgenic model of spontaneous eye cancer. Mol Ther 2003; 7: 174-183.
21. Dong Z, Kumar R, Yang X, Fidler I. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 1997; 88: 801-810.
22. Griscelli F et al. Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation with a mitosis arrest. Proc Natl Acad Sci USA 1998; 95: 6367-6372.
23. Griscelli F et al. Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model. Proc Natl Acad Sci USA 2000; 97: 6698-6703.
24. Galaup A et al. Combined effects of docetaxel and angiostatin gene therapy in prostate tumor model. Mol Ther 2003; 6: 731-740.
25. Bergers G et al. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 1999; 284: 808-812.
26. Troyanovsky B et al. Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation. J Cell Biol 2001; 152: 1247-1254.
27. Brooks PC et al. Integrin alpha vs beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994; 79: 1157-1164.
28. Claesson-Welsh L et al. Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. Proc Natl Acad Sci USA 1998; 95: 5579-5583.
29. Moser TL et al. Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc Natl Acad Sci USA 1999; 96: 2811-2816.
30. Crouzet J et al. Recombinational construction in Escherichia coli of infectious adenoviral genomes. Proc Natl Acad Sci USA 1997; 18: 1414-1419.
31. Stratford-Perricaudet L, Maked I, Perricaudet M, Briand P. Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest 1992; 90: 626-630.
32. Tamura M et al. Inhibition of cell migration spreading, focal adhesions by tumor suppressor PTEN. Science 1998; 280: 1614-1617.